Dr. Yarchoan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 North Broadway Street
Viragh BLDG 5th FL
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2016 - 2018
University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012
Certifications & Licensure
MD State Medical License 2015 - 2025
NC State Medical License 2021 - 2022
PA State Medical License 2012 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers Start of enrollment: 2019 Mar 20
- National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer Start of enrollment: 2021 Jul 28
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma Start of enrollment: 2020 Apr 20
Publications & Presentations
PubMed
- Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1-mutant cholangiocarcinoma.Daniel J Zabransky, Emma Kartalia, Jae W Lee, James M Leatherman, Soren Charmsaz
Hepatology. 2024-12-03 - SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in Tumors.Theron Palmer, Michael D Kessler, Xiaoshan M Shao, Archana Balan, Mark Yarchoan
Cancer Research Communications. 2024-12-01 - Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy.Tracee L McMiller, Sepideh Besharati, Mark Yarchoan, Qingfeng Zhu, Keziban Ünsal-Kaçmaz
Journal for Immunotherapy of Cancer. 2024-11-20
Journal Articles
- Effects of B Cell–Activating Factor on Tumor ImmunityMark Yarchoan, MD, The Journal of Clinical Investigation
- Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology ClinicMark Yarchoan, Elizabeth Jaffee, Annals of Oncology
- Immuno-Oncology Trial Endpoints: Capturing Clinically Meaningful ActivityElad Sharon, Patrick M Forde, Valsamo Anagnostou, Hao Wang, Franco Verde, Mark Yarchoan, Clinical Cancer Research
Authored Content
- Effects of B Cell–Activating Factor on Tumor ImmunityMay 2020
Press Mentions
Lymph Node-like Structures May Trigger the Demise of Cancer TumoursOctober 30th, 2024- Tertiary Lymphoid Structures Linked to Improved Treatment Outcomes in Liver CancerOctober 28th, 2024
- Lymph Node-like Structures May Trigger the Demise of Cancer TumorsOctober 25th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
